Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
244.68 USD | -0.19% |
|
-0.41% | +15.16% |
Jul. 11 | TD Cowen Adjusts Analog Devices' Price Target to $285 From $250, Keeps Buy Rating | MT |
Jul. 08 | KeyBanc Adjusts Price Target on Analog Devices to $300 From $285, Maintains Overweight Rating | MT |
Fiscal Period: November | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.58 | 3.56 | 4.65 | 5.02 | 2.66 | |||||
Return on Total Capital | 5.6 | 4.19 | 5.4 | 5.75 | 2.99 | |||||
Return On Equity % | 10.3 | 5.56 | 7.38 | 9.2 | 4.62 | |||||
Return on Common Equity | 10.3 | 5.56 | 7.38 | 9.2 | 4.62 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.87 | 66.36 | 64.96 | 64.01 | 57.08 | |||||
SG&A Margin | 11.44 | 12.55 | 10.57 | 10.39 | 11.41 | |||||
EBITDA Margin % | 42.48 | 43.44 | 50.93 | 50.97 | 44.21 | |||||
EBITA Margin % | 38.31 | 40.28 | 48.57 | 48.25 | 40.36 | |||||
EBIT Margin % | 28.01 | 28.76 | 31.8 | 32.33 | 21.89 | |||||
Income From Continuing Operations Margin % | 21.79 | 19 | 22.88 | 26.94 | 17.35 | |||||
Net Income Margin % | 21.79 | 19 | 22.88 | 26.94 | 17.35 | |||||
Net Avail. For Common Margin % | 21.79 | 19 | 22.88 | 26.94 | 17.35 | |||||
Normalized Net Income Margin | 15.44 | 16.73 | 18.96 | 19.14 | 12.03 | |||||
Levered Free Cash Flow Margin | 28.02 | 18.12 | 35.84 | 26.93 | 31.36 | |||||
Unlevered Free Cash Flow Margin | 30.18 | 19.7 | 36.88 | 28.27 | 33.5 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.26 | 0.2 | 0.23 | 0.25 | 0.19 | |||||
Fixed Assets Turnover | 4.31 | 4.03 | 4.88 | 3.99 | 2.64 | |||||
Receivables Turnover (Average Receivables) | 8.16 | 6.66 | 7.37 | 7.53 | 6.72 | |||||
Inventory Turnover (Average Inventory) | 3.14 | 2.72 | 3.24 | 2.91 | 2.62 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.84 | 1.94 | 2.02 | 1.37 | 1.84 | |||||
Quick Ratio | 1.31 | 1.24 | 1.34 | 0.76 | 1.24 | |||||
Operating Cash Flow to Current Liabilities | 1.47 | 0.99 | 1.83 | 1.51 | 1.29 | |||||
Days Sales Outstanding (Average Receivables) | 44.59 | 54.63 | 49.38 | 48.37 | 55.22 | |||||
Days Outstanding Inventory (Average Inventory) | 115.92 | 133.71 | 112.42 | 125.03 | 141.67 | |||||
Average Days Payable Outstanding | 43.1 | 39.96 | 42.33 | 41.9 | 47.23 | |||||
Cash Conversion Cycle (Average Days) | 117.41 | 148.37 | 119.47 | 131.5 | 149.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 47.41 | 18.74 | 19.03 | 20.96 | 22.76 | |||||
Total Debt / Total Capital | 32.16 | 15.78 | 15.99 | 17.33 | 18.54 | |||||
LT Debt/Equity | 45.29 | 17.24 | 18.88 | 17.61 | 19.77 | |||||
Long-Term Debt / Total Capital | 30.72 | 14.52 | 15.86 | 14.56 | 16.1 | |||||
Total Liabilities / Total Assets | 44.11 | 27.39 | 27.51 | 27.11 | 27.06 | |||||
EBIT / Interest Expense | 8.12 | 11.39 | 19.06 | 15.04 | 6.4 | |||||
EBITDA / Interest Expense | 12.55 | 17.48 | 30.83 | 23.9 | 13.11 | |||||
(EBITDA - Capex) / Interest Expense | 11.69 | 15.62 | 27.34 | 19.14 | 10.84 | |||||
Total Debt / EBITDA | 2.34 | 2.2 | 1.12 | 1.18 | 1.9 | |||||
Net Debt / EBITDA | 1.91 | 1.59 | 0.89 | 1.03 | 1.34 | |||||
Total Debt / (EBITDA - Capex) | 2.52 | 2.47 | 1.27 | 1.47 | 2.29 | |||||
Net Debt / (EBITDA - Capex) | 2.05 | 1.78 | 1 | 1.28 | 1.62 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.48 | 30.61 | 64.16 | 2.43 | -23.39 | |||||
Gross Profit, 1 Yr. Growth % | -8.05 | 31.58 | 60.7 | 0.94 | -31.68 | |||||
EBITDA, 1 Yr. Growth % | -9.07 | 34.68 | 92.45 | 2.51 | -33.55 | |||||
EBITA, 1 Yr. Growth % | -9.69 | 38.61 | 97.94 | 1.76 | -35.92 | |||||
EBIT, 1 Yr. Growth % | -13.12 | 35.81 | 81.55 | 4.14 | -48.14 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -10.44 | 13.9 | 97.68 | 20.59 | -50.66 | |||||
Net Income, 1 Yr. Growth % | -10.44 | 13.9 | 97.68 | 20.59 | -50.66 | |||||
Normalized Net Income, 1 Yr. Growth % | -12.81 | 43.66 | 86.01 | 3.4 | -51.85 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -10.14 | 5.49 | 51.73 | 24.76 | -49.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.12 | 97.83 | 23.4 | -18.37 | -9.08 | |||||
Inventory, 1 Yr. Growth % | -0.27 | 97.38 | 16.6 | 17.31 | -11.85 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 12.89 | 64 | 17.96 | 31.23 | 4.63 | |||||
Total Assets, 1 Yr. Growth % | 0.36 | 143.71 | -3.86 | -3 | -1.16 | |||||
Tangible Book Value, 1 Yr. Growth % | -17.51 | 6.67 | -11.44 | -28.36 | -50.42 | |||||
Common Equity, 1 Yr. Growth % | 2.47 | 216.66 | -4.02 | -2.47 | -1.09 | |||||
Cash From Operations, 1 Yr. Growth % | -10.86 | 36.18 | 63.63 | 7.65 | -20.03 | |||||
Capital Expenditures, 1 Yr. Growth % | -39.83 | 107.42 | 103.48 | 80.39 | -42.09 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -8.51 | -14.85 | 224.58 | -23.03 | -10.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -9.06 | -14.1 | 207.26 | -21.47 | -9.22 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.81 | 11.29 | 10.14 | 13.16 | 6.98 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -5.12 | 10.52 | 46.43 | 29.67 | -11.42 | |||||
Gross Profit, 2 Yr. CAGR % | -6.82 | 9.99 | 45.42 | 27.36 | -16.96 | |||||
EBITDA, 2 Yr. CAGR % | -7.11 | 10.2 | 60.99 | 40.46 | -17.47 | |||||
EBITA, 2 Yr. CAGR % | -7.89 | 11.36 | 65.64 | 41.92 | -19.25 | |||||
EBIT, 2 Yr. CAGR % | -10.51 | 7.93 | 57.02 | 37.5 | -26.51 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -10 | 1 | 50.05 | 54.4 | -22.87 | |||||
Net Income, 2 Yr. CAGR % | -10 | 1 | 50.05 | 54.4 | -22.87 | |||||
Normalized Net Income, 2 Yr. CAGR % | -10.19 | 11.31 | 63.47 | 38.69 | -29.44 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -9.45 | -2.64 | 26.52 | 37.59 | -20.96 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.37 | 51.57 | 56.24 | 0.37 | -13.85 | |||||
Inventory, 2 Yr. CAGR % | 1.82 | 40.31 | 51.71 | 16.95 | 1.69 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.23 | 36.06 | 39.09 | 24.42 | 17.18 | |||||
Total Assets, 2 Yr. CAGR % | 2.49 | 56.39 | 53.07 | -3.43 | -2.08 | |||||
Tangible Book Value, 2 Yr. CAGR % | -17.41 | -6.19 | -2.81 | -20.35 | -40.4 | |||||
Common Equity, 2 Yr. CAGR % | 3.19 | 80.13 | 74.34 | -3.25 | -1.78 | |||||
Cash From Operations, 2 Yr. CAGR % | -9.32 | 10.18 | 49.27 | 32.72 | -7.22 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.37 | 11.72 | 105.44 | 91.59 | 2.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 3.77 | -12.09 | 66.25 | 58.06 | -17.13 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 2.27 | -11.94 | 62.47 | 55.33 | -15.57 | |||||
Dividend Per Share, 2 Yr. CAGR % | 13.65 | 13.04 | 10.72 | 11.64 | 10.02 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.22 | 5.54 | 26.1 | 29.98 | 8.81 | |||||
Gross Profit, 3 Yr. CAGR % | 1.52 | 4.54 | 24.81 | 28.75 | 3.48 | |||||
EBITDA, 3 Yr. CAGR % | 2.64 | 4.84 | 32.71 | 38.51 | 9.45 | |||||
EBITA, 3 Yr. CAGR % | 2.28 | 5.22 | 34.9 | 40.81 | 8.88 | |||||
EBIT, 3 Yr. CAGR % | -0.99 | 2.4 | 28.36 | 36.94 | -0.65 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 14.87 | -2.65 | 26.34 | 39.51 | 5.56 | |||||
Net Income, 3 Yr. CAGR % | 14.87 | -2.65 | 26.34 | 39.51 | 5.56 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.26 | 4.51 | 32.09 | 40.32 | -2.53 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 12.72 | -4.72 | 12.88 | 25.93 | -1.77 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.3 | 31.63 | 41.53 | 25.84 | -2.89 | |||||
Inventory, 3 Yr. CAGR % | 3.36 | 26.95 | 31.91 | 39.25 | 6.44 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.54 | 25.07 | 29.74 | 36.42 | 17.44 | |||||
Total Assets, 3 Yr. CAGR % | 0.51 | 36.8 | 32.98 | 31.48 | -2.68 | |||||
Tangible Book Value, 3 Yr. CAGR % | -18.92 | -10.06 | -7.98 | -12.21 | -31.99 | |||||
Common Equity, 3 Yr. CAGR % | 5.69 | 49.95 | 46.03 | 43.65 | -2.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 20.28 | 3.85 | 25.7 | 33.86 | 12.1 | |||||
Capital Expenditures, 3 Yr. CAGR % | -6.71 | 10.48 | 36.43 | 96.72 | 28.57 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.29 | -3.11 | 35.88 | 28.61 | 30.63 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.36 | -3.74 | 33.57 | 27.5 | 29.87 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.27 | 12.86 | 12.07 | 11.52 | 10.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.28 | 16.42 | 18.02 | 14.6 | 9.49 | |||||
Gross Profit, 5 Yr. CAGR % | 10.31 | 16.87 | 17.21 | 13.13 | 6.04 | |||||
EBITDA, 5 Yr. CAGR % | 17.72 | 20.49 | 22.69 | 17.85 | 9.75 | |||||
EBITA, 5 Yr. CAGR % | 18.39 | 21.42 | 23.8 | 18.6 | 9.87 | |||||
EBIT, 5 Yr. CAGR % | 13.57 | 15.1 | 18.76 | 15.22 | 2.7 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.87 | 10.04 | 27.83 | 17.08 | 3.71 | |||||
Net Income, 5 Yr. CAGR % | 11.87 | 10.04 | 27.83 | 17.08 | 3.71 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.31 | 14.94 | 21.17 | 17.03 | 2.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.32 | 4.62 | 18.05 | 10.37 | -2.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.59 | 25.03 | 21.18 | 18.1 | 16.04 | |||||
Inventory, 5 Yr. CAGR % | 8.09 | 26.1 | 20.51 | 22.86 | 18.87 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.41 | 28.84 | 19.2 | 24.81 | 24.56 | |||||
Total Assets, 5 Yr. CAGR % | 24.92 | 45.69 | 18.93 | 19.01 | 17.65 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.62 | 7.38 | -12.82 | -14.33 | -22.65 | |||||
Common Equity, 5 Yr. CAGR % | 18.79 | 49.04 | 29.12 | 25.84 | 24.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 17.21 | 16.19 | 31.13 | 14.55 | 11.33 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.48 | 21.95 | 27.93 | 37.69 | 21.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 24.19 | 6.91 | 24.03 | 17.84 | 11.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 25.26 | 7.48 | 22.23 | 16.57 | 11.18 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.16 | 10.44 | 11.05 | 12.37 | 11.24 |
- Stock Market
- Equities
- ADI Stock
- Financials Analog Devices, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions